Elite Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Elite Pharmaceuticals, Inc. (ELTP) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $183.97 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-13
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $183.97K.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $221.60K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $262.35K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $306.13K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount as first filed |
|---|---|---|
| 2026-06-30 | $183.97K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $221.60K 10-K · filed 2026-06-29 | |
| 2025-12-31 | $262.35K 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $306.13K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $352.81K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $402.30K 10-K · filed 2025-06-30 | |
| 2024-12-31 | $454.55K 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $498.16K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $553.90K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $612.12K 10-K · filed 2024-07-01 | |
| 2023-12-31 | $727.00 10-Q · filed 2024-02-14 | |
| 2023-03-31 | $108.00 10-Q · filed 2023-08-14 | $300.00 10-K · filed 2023-06-29 |
| 2022-12-31 | $21.00 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $202.00 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $140.90K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $156.24K 10-K · filed 2022-06-29 | |
| 2021-12-31 | $172.31K 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $173.60K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $175.80K 10-Q · filed 2021-08-16 | |
| 2019-12-31 | $27.21K 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $34.07K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $41.64K 10-Q · filed 2019-08-09 |